Pushing a new model for TB drugs

Vertex Pharmaceuticals Inc. has been working quietly on a tuberculosis drug development program for a year, but now is looking for philanthropic funding to advance the program. The idea is to recapitulate its collaboration with the Cystic Fibrosis Foundation, which has produced two novel compounds that are in Phase II and Phase I trials.

Vertex disclosed its TB program at a recent partnering forum organized by BIO Ventures for Global Health (BVGH), a not-for-profit organization dedicated to facilitating the application of the biotech industry's skills and resources to neglected diseases of the developing world. ...